• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为自闭症及相关神经发育障碍的跨诊断亚组确定可靶向的分子通路。

Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental Disorders.

作者信息

Ellegood Jacob, Beauchamp Antoine, Yee Yohan, Devenyi Gabe, Ziolkowski Justine, Qiu Lily, Askalan Rand, Ayub Muhammad, Suetterlin Philipp, Donovan Alex, Basson M Albert, Quesnel Katherine M, Berube Nathalie G, Woo Taeseon, Beversdorf David, Bjornsson Hans, Blakely Randy, Crawley Jacqueline, Crosbie Jennifer, Orr Brian O, Davis Graeme W, Genestine Matthew, DiCicco-Bloom Emanuel, Egan Sean, Fink Kyle D, Asbury Sarah, Lai Jonathan, Rilett Kelly, Foster Jane A, Vincent John B, Frankland Paul, Georgiades Stelios, Penagarikano Olga, Geschwind Daniel, Giger Roman J, Markx Sander, Gogos Joseph, Golzio Christelle, Pagani Marco, Gozzi Alessandro, Pacey Laura K, Hampson David, Huang Tzyy-Nan, Yen Tzu-Li, Hsueh Yi-Ping, Iaboni Alana, Amar Megha, Iakoucheva Lilia M, Jones Jessica K, Kelly Elizabeth, Kieffer Brigette, Bae Mihyun, Jung Hwajin, Kim Hyosang, Park Haram, Roh Junye Daniel, Kim Eunjoon, Konopka Genevieve, Laliberte Christine, Lefebvre Julie L, Eagleson Kathie, Levitt Pat, Bach Aurea Martins, Cunningham Thomas J, Fisher Elizabeth, Miller Karla, Mills Alea, Muotri Alyson, Nicolson Rob, Noakes Leigh Spencer, Nieman Brian J, Canales Cesar P, Nord Alex S, Nutter Lauryl Mj, Tam Elaine, Osborne Lucy R, Clipperton-Allen Amy, Page Damon, Babineau Brooke, Palmer Theo D, Yan Keqin, Picketts David, Xia Qiangqiang, Powell Craig M, Raznahan Armin, Robins Diane M, Rumbaugh Gavin, Sengar Ameet S, Salter Michael William, Schachar Russell James, D'Abate Lia, Bradley Clarissa A, Scherer Stephen W, Copping Nycole W, Petkova Stela P, Silverman Jill L, Singh Karun Kar, Kim Nam-Shik, Yoon Ki-Jun Kar, Ming Guo-Li, Song Hongjun, Spring Shoshana, Nakatani Jin, Nakai Nobuhiro, Nomura J, Takumi Toru, Taylor Margot, Tsai Peter, Bruce Matthew, Jones Karen L, Van de Water Judy, Van Eede Matthijs C, Kerr Travis M, Muller Christopher L, VanderWeele Jeremy Veenstra, Vandewouw Marlee, Weksberg Rosanna, Wevrick Rachel, Belinson Haim, Wynshaw-Boris Anthony, Zarbalis Konstantinos, Trost Brett, Mars Rogier B, Chakravarty Mallar, Kushki Azadek, Anagnostou Evdokia, Lerch Jason P

出版信息

bioRxiv. 2025 Mar 8:2025.03.04.641443. doi: 10.1101/2025.03.04.641443.

DOI:10.1101/2025.03.04.641443
PMID:40568076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12191138/
Abstract

Significant genetic, behavioural and neuroanatomic heterogeneity is common in autism spectrum- and related- neurodevelopmental disorders (NDDs). This heterogeneity constrains the development of effective therapies for diverse patients in precision medicine paradigms. This has led to the search for subgroups of individuals having common etiologic factors/biology (e.g., genetic pathways), thus creating potential uniformity in prognosis and/or treatment response. Despite NDDs having a strong genetic component, only ~15-20% of individuals will present with a specific rare genetic variant considered clinically pathogenic, and therefore, subtyping efforts tend to focus on using clinical, cognitive, and/or brain imaging phenotypes to group individuals. Here we delineated mechanisms via mouse to human translational neuroscience. Using MRI derived structural neuroanatomy and a spatial transcriptomic comparison, we linked subgroups of 135 NDD relevant mouse models (3,515 individual mice) separately to two human databases, with 1,234 and 1,015 human individuals with NDDs, composed of autism, attention-deficit/hyperactivity disorder (ADHD), obsessive compulsive disorder (OCD), other related NDDs, and typically developing controls. Subgroups were significantly linked by consistent neuroanatomy across all three datasets, mouse and human, indicating that direct cross-species subgrouping and translation is consistent and reproducible. Ultimately, four specific neuroanatomical clusters were found and linked to precise molecular mechanisms: two showing a chromatin/transcription motif, with one of those showing specific links to G-protein coupled receptors (GPCR) and Notch signalling, and another two being mainly synaptic in origin, with one off those showing specific connections to axon guidance and Wnt signaling. Assigning molecular pathways, and thus genetic information, from the mouse to individual participants provides an insight into undetected and/or related genetic variants that could be working in combination or interacting with an environmental influence. Moreover, the subgroups found are transdiagnostic, including participants with autism, ADHD, and OCD, which indicates that NDDs as a whole can be subdivided into consistent neuroanatomical clusters with cohesive underlying biological mechanisms. This work allows us to bridge the gap between preclinical models and human disorders, linking previously idiopathic human patients to pertinent genetics, molecular mechanisms, and pathways.

摘要

显著的遗传、行为和神经解剖学异质性在自闭症谱系及相关神经发育障碍(NDDs)中很常见。这种异质性限制了精准医学模式下针对不同患者的有效治疗方法的开发。这促使人们寻找具有共同病因因素/生物学特征(如遗传途径)的个体亚组,从而在预后和/或治疗反应方面创造潜在的一致性。尽管NDDs具有很强的遗传成分,但只有约15 - 20%的个体将表现出被认为具有临床致病性的特定罕见遗传变异,因此,亚型分类工作往往侧重于使用临床、认知和/或脑成像表型对个体进行分组。在这里,我们通过从小鼠到人类的转化神经科学描绘了相关机制。利用磁共振成像(MRI)得出的结构神经解剖学和空间转录组比较,我们将135个与NDD相关的小鼠模型(3515只个体小鼠)的亚组分别与两个人类数据库相联系,这两个人类数据库分别包含1234名和1015名患有NDDs的个体,这些个体包括自闭症、注意力缺陷多动障碍(ADHD)、强迫症(OCD)、其他相关NDDs患者以及典型发育的对照者。所有三个数据集(小鼠和人类)中一致的神经解剖学特征显著地将这些亚组联系起来,表明直接的跨物种亚组分类和转化是一致且可重复的。最终,发现了四个特定的神经解剖学集群,并将其与精确的分子机制联系起来:两个显示出染色质/转录基序,其中一个显示出与G蛋白偶联受体(GPCR)和Notch信号传导的特定联系,另外两个主要起源于突触,其中一个显示出与轴突导向和Wnt信号传导的特定联系。从小鼠到个体参与者确定分子途径以及由此确定遗传信息,能够深入了解可能共同起作用或与环境影响相互作用的未被检测到的和/或相关的遗传变异。此外,所发现的亚组具有跨诊断性,包括自闭症、ADHD和OCD患者,这表明整个NDDs可以细分为具有内在连贯生物学机制的一致神经解剖学集群。这项工作使我们能够弥合临床前模型与人类疾病之间的差距,将以前病因不明的人类患者与相关的遗传学、分子机制和途径联系起来。

相似文献

1
Assigning Targetable Molecular Pathways to Transdiagnostic Subgroups Across Autism and Related Neurodevelopmental Disorders.为自闭症及相关神经发育障碍的跨诊断亚组确定可靶向的分子通路。
bioRxiv. 2025 Mar 8:2025.03.04.641443. doi: 10.1101/2025.03.04.641443.
2
Short-Term Memory Impairment短期记忆障碍
3
Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).针对自闭症谱系障碍(ASD)个体的强迫症(OCD)的行为和认知行为疗法。
Cochrane Database Syst Rev. 2021 Sep 3;9(9):CD013173. doi: 10.1002/14651858.CD013173.pub2.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
Differently different?: A commentary on the emerging social cognitive neuroscience of female autism.别样不同?:女性自闭症社会认知神经科学的新发展述评。
Biol Sex Differ. 2024 Jun 13;15(1):49. doi: 10.1186/s13293-024-00621-3.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
8
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.

引用本文的文献

1
Integrons: the hidden architects of bacterial adaptation, evolution, and the challenges of antimicrobial resistance.整合子:细菌适应性、进化及抗菌药物耐药性挑战背后的隐秘构建者
Antonie Van Leeuwenhoek. 2025 Jun 12;118(7):90. doi: 10.1007/s10482-025-02103-x.